Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
1.
Arch Immunol Ther Exp (Warsz) ; 23(2): 277-83, 1975.
Artigo em Inglês | MEDLINE | ID: mdl-238489

RESUMO

Biochemical disorders accompanying posttransfusion shock in cats under protection by selective cerebral hypothermia, by our own method was studied in cats. In 11 of 22 cats, selective cerebral hypothermia was performed before transfusion of human group A blood. In 11 control cats, transfusions were made without prior selective cerebral hypothermia. The following parameters were determined in venous blood: pH, pCO2, HCO3, content and excess of buffer bases. Selective cerebral hypothermia diminished mortality in cats in posttransfusion shock and reduced the intensity of the biochemical changes accompanying shock.


Assuntos
Encéfalo , Crioterapia , Choque/terapia , Animais , Dióxido de Carbono/sangue , Gatos , Humanos , Concentração de Íons de Hidrogênio , Hipotermia Induzida , Choque/etiologia , Especificidade da Espécie , Reação Transfusional
2.
Arch Immunol Ther Exp (Warsz) ; 23(3): 379-83, 1975.
Artigo em Inglês | MEDLINE | ID: mdl-3148

RESUMO

In 111 rats divided into 5 groups, Ipronal (5-allyl-5-(beta-hydroxypropyl)-barbituric acid) protected rats from development of experimental ulceration of the gastric mucosa twice as effectively as diallylbarbituric acid and compound D2H (5-isopropyl-5-(beta-hydroxypropyl)-barbituric acid). Compound D1S (alpha-allophanyl-alpha-allyl-gamma-valerolactone) was devoid of this action.


Assuntos
Barbitúricos/uso terapêutico , Úlcera Gástrica/prevenção & controle , Animais , Sistema Nervoso Autônomo/efeitos dos fármacos , Barbitúricos/farmacologia , Feminino , Mucosa Gástrica/inervação , Masculino , Ratos
3.
Acta Haematol Pol ; 12(3-4): 155-9, 1981.
Artigo em Polonês | MEDLINE | ID: mdl-7342655

RESUMO

On the basis of standardized protocols of the therapeutic results of acute non-lymphoblastic leukaemias in adults sent to the Institute of Haematology in Warsaw from 8 haematological centres in Poland it was demonstrated that complete remission occurred in 34.4% of patients (129 out of 375 cases). The mean survival time of the patients treated intensively according to programmes I, II, III and IV 8.6 months, those of patients with complete remission - 13.5 months, patients without complete remission - 3.7 months. The most frequent cause of death (82.5%) were infections and/or haemarrhagic diathesis.


Assuntos
Institutos de Câncer , Hematologia , Hospitais Especializados , Leucemia/tratamento farmacológico , Doença Aguda , Adulto , Humanos , Leucemia/complicações , Leucemia/mortalidade , Polônia
9.
Kardiol Pol ; 22(4): 361-4, 1979.
Artigo em Polonês | MEDLINE | ID: mdl-491339
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA